Ascendis Pharma A/S (ASND)
210.47
-0.55
(-0.26%)
USD |
NASDAQ |
Dec 30, 10:53
Ascendis Pharma EPS Diluted (Quarterly): -1.173 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7044 |
| Evaxion AS | -0.2862 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -71.27M |
| Revenue (Quarterly) | 249.64M |
| Total Expenses (Quarterly) | 320.91M |
| Enterprise Value | 13.22B |
| Gross Profit Margin (Quarterly) | 87.87% |
| Profit Margin (Quarterly) | -28.55% |
| Earnings Yield | -2.02% |
| Normalized Earnings Yield | -2.018 |